Reduced Glutathione Sodium
Tier C — Watch / tradeReduced Glutathione Sodium
Targets：Not applicable
Indications (approved)：Acute respiratory distress syndrome, Liver disease, 酒精性肝炎, 酒精性肝硬化, 酒精性脂肪肝病, Sepsis, Anaemia
Regional status
Factories producing this API2
Factories registered as producing this API in our sourcing network (RFQ records + product master), sorted by RFQ activity; the snapshot carries no cost or customer data.
2 producing factories on file — sign in to view the named list (factory details are not shown to guests).
Sign in to view factories →Synthetic routes & intermediates
Frequently asked questions
What are the approved indications of Reduced Glutathione Sodium?
Approved indications include: Acute respiratory distress syndrome, Liver disease, 酒精性肝炎, 酒精性肝硬化, 酒精性脂肪肝病, Sepsis, Anaemia.
When does the Reduced Glutathione Sodium patent expire?
No public expiry year is available for Reduced Glutathione Sodium yet; this page updates once verified.
How do I get a quote for Reduced Glutathione Sodium intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27